ProfileGDS4095 / 204706_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 76% 75% 75% 73% 75% 74% 75% 74% 77% 75% 75% 75% 75% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.9929276
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.9035575
GSM709765LY2 SRC1-siRNA untreated rep37.9057175
GSM709771LY2 SRC1-siRNA untreated rep17.4134473
GSM709772LY2 SRC1-siRNA untreated rep27.9311675
GSM709775LY2 SRC1-siRNA untreated rep47.7375674
GSM709764LY2 control-siRNA tamoxifen treated rep27.7505675
GSM709766LY2 control-siRNA tamoxifen treated rep37.6172874
GSM709768LY2 control-siRNA tamoxifen treated rep18.1790277
GSM709777LY2 control-siRNA tamoxifen treated rep47.8640575
GSM709770LY2 control-siRNA untreated rep37.9168875
GSM709773LY2 control-siRNA untreated rep17.9178575
GSM709774LY2 control-siRNA untreated rep27.7968475
GSM709776LY2 control-siRNA untreated rep47.8726975